Wednesday, October 23, 2019
2:00–4:00 p.m.


Center for Recreation and Sports, Campbell Lounge 3

Psychedelic Research: Implications for Palliative Care and End-of-Life Existential Distress

The past decade of research into psychedelics is yielding exciting results. Clinical trials at NYU show that Psilocybin, the active ingredient in so-called magic mushrooms, may be useful in treating a host of maladies including end of life distress. One researcher is quoted as saying that under the influence of the hallucinogen, “individuals transcend their primary identification with their bodies and experience ego-free states…and return with a new perspective and profound acceptance.”

About the Lecturer

Anthony Bossis, PhD is a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine where he is conducting FDA approved psychedelic research investigating the therapeutic efficacy of psilocybin on existential and psycho-spiritual distress at the end of life. He is Director of Palliative Care Research, Co-Principal Investigator, and a session guide for the NYU Psilocybin Cancer Anxiety Project and on the advisory committee and faculty for the Art of Dying Institute in New York City.

Dr. Bossis has a long-standing interest in comparative religion, consciousness research, and the interface of psychology and spirituality. He writes and lectures on chronic pain, psycho-spiritual and existential themes in end-of-life. He maintains a private consulting and psychotherapy practice in NYC.


For further information, please contact:

Gordon F. Derner School of Psychology
p – 516.877.4800